MedTrace Logo

Action of Intra-auricular Topical Lidocaine on Tinnitus

NCT05711641 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2024-08-30

Study results available
· View outcomes & findings →

Summary

The main objective of this clinical trial placebo controled is to evaluate the action of intraauricular topical lidocaine on tinnitus.

The question to be answered is whether lidocaine is superior to placebo (distilled water) in reducing tinnitus intensity when applied topically within the external auditory canal.

Tinnitus intensity will be measured using the visual analog scale and acuphenometry before and after lidocaine or placebo application.

Conditions

  • Tinnitus, Subjective

Interventions

DRUG

Lidocaine 10 MG/ML

Application of 10% topical lidocaine in the external auditory canal of tinnitus patients.

DRUG

Distilled water

Application of distilled water in the external auditory canal of tinnitus patients.

Sponsors & Collaborators

  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Ricardo F Bento · University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-02
Primary Completion
2023-06-01
Completion
2023-06-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05711641 on ClinicalTrials.gov